Introduction
Cell Adhesion Molecule 1, also known as CADM1, is a member of the nectin family. This molecule facilitates both homophilic cell-cell adhesion in a calcium-independent manner and heterophilic cell-cell adhesion with CADM3 and PVRL3, also in a calcium-independent manner. CADM1 acts as a tumor suppressor in non-small-cell lung cancer (NSCLC) cells. Its interaction with CRTAM promotes natural killer (NK) cell cytotoxicity and interferon gamma (IFN-γ) secretion by CD8+ cells in vitro. This interaction also enhances NK cell-mediated rejection of tumors expressing CADM3 in vivo.
Description
Recombinant human CADM1, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 353 amino acids (45-374 a.a.). It has a molecular mass of 39.4 kDa. The protein includes a 23 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile, colorless solution.
Formulation
The CADM1 protein solution is provided at a concentration of 0.25 mg/ml and contains phosphate-buffered saline (pH 7.4), 10% glycerol, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freezing at -20°C is recommended. To ensure optimal stability during long-term storage, the addition of a carrier protein (0.1% HSA or BSA) is advised. Repeated freeze-thaw cycles should be avoided.
Purity
Purity is determined to be greater than 85.0% by SDS-PAGE analysis.
Synonyms
Cell Adhesion Molecule 1, Tumor Suppressor In Lung Cancer
1, IGSF4, Spermatogenic Immunoglobulin Superfamily, Immunoglobulin Superfamily,
Member 4, Immunoglobulin Superfamily Member 4, Synaptic Cell Adhesion Molecule,
Nectin-Like Protein 2, Nectin-Like 2, Necl-2, SgIGSF, IGSF4A, SYNCAM, TSLC-1,
TSLC1, NECL2, Immunoglobulin Superfamily, Member 4D Variant 1, Immunoglobulin Superfamily,
Member 4D Variant 2, TSLC1/Nectin-Like 2/IGSF4, Truncated CADM1 Protein,
STSLC-1, SynCAM1, RA175, ST17, BL2, Cell adhesion molecule 1.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSQNLFTKD VTVIEGEVAT ISCQVNKSDD SVIQLLNPNR QTIYFRDFRP
LKDSRFQLLN FSSSELKVSL TNVSISDEGR YFCQLYTDPP QESYTTITVL VPPRNLMIDI QKDTAVEGEE
IEVNCTAMAS KPATTIRWFK GNTELKGKSE VEEWSDMYTV
TSQLMLKVHK EDDGVPVICQ VEHPAVTGNL QTQRYLEVQY KPQVHIQMTY
PLQGLTREGD ALELTCEAIG KPQPVMVTWV RVDDEMPQHA VLSGPNLFIN NLNKTDNGTY RCEASNIVGK
AHSDYMLYVY DPPTTIPPPT TTTTTTTTTT TTILTIITDS RAGEEGSIRA VDH.